IP Policy Committee blog

TransAtlantic Consumer Dialogue (TACD)

Main menu

Skip to content
  • About
  • Director General of WIPO speaks about new copyright model
  • Documents
  • Events
    • Paris Accord
Uncategorized

Open access to scientific publications and data approved in EU´s Horizon 2020 research programme

by david • November 28, 2012

1. If a decision to publish is taken, open access to scientific publications stemming from research which receive public funding from Horizon 2020 shall be mandatory (46, 528, 532). 2. Furthermore, open access to scientific data resulting from publicly funded…

Read more →

Uncategorized

Blind Treaty on the brink: today moment of truth

by david • November 23, 2012

It is still not clear whether a diplomatic conference will be convened or not to put the final touches on and to sign a Treaty.  Negotiations continue today. The main difference now is “commercial availability” whereas the exception cannot be…

Read more →

Uncategorized

EU finally supports binding Treaty Visually Impaired: offical statement at WIPO

by david • November 19, 2012

On 19 November 2012, the European Union announced to WIPO’s Standing Committee on Copyright and Related Rights (SCCR) that it now had the mandate to “negotiate the conclusion conclusion of an instrument including a binding treaty” for the blind. EUROPEAN…

Read more →

Uncategorized

Watering down Open Access in EU (latest compromise)

by david • November 14, 2012

Bold print are latest changes proposed in text. Final vote on November 28th in Industry Committee. Pressure on MEPs is necessary.   Proposal for a regulation Article 40 Protection of results Text proposed by the Commission Amendment 1. Each participant…

Read more →

Uncategorized

“Opening up EU clinical trial data” lunch event in EP, Brussels, 13-11-12

by david • October 24, 2012

TRANSPARENCY IN MEDICAL RESEARCH TO PROTECT PUBLIC HEALTH: Opening up EU clinical trial data for safe and effective medicines “Doctors can have no idea about the true effects of the treatments they give. Does this drug really work, or have…

Read more →

Uncategorized

“Transparency and protecting public health: clinical trials in EU”

by david • October 24, 2012

Invitation 13 Nov 2012

Read more →

Page 23 of 48
« 1 … 21 22 23 24 25 … 48 »

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Archives

Categories

Copyright © 2025 IP Policy Committee blog . All Rights Reserved. The Magazine Basic Theme by bavotasan.com.